Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Oncolysin B effective in tumor models in mice; phase II trials underway

May 10, 1996

Agouron reports phase II data for Thymitaq

May 3, 1996

Hybridon reports oligonucleotide MDR inhibitors

May 3, 1996

Vertex dedicates significant efforts to MDR-reversing agents

May 3, 1996

Receptagen will develop vitamin B12 uptake inhibitors

May 3, 1996

Somatix receives patent protection for novel glioma treatment

May 3, 1996

NSAID blocks carcinogenesis in rodent models

May 3, 1996

Targretin clinical trials update

May 3, 1996

Eisai presents preliminary data on ER-34335

May 3, 1996

AG-3340 on track for clinical testing

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...